vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and Millrose Properties, Inc. (MRP). Click either name above to swap in a different company.

Millrose Properties, Inc. is the larger business by last-quarter revenue ($189.5M vs $150.6M, roughly 1.3× GLAUKOS Corp). Millrose Properties, Inc. runs the higher net margin — 64.5% vs 6.2%, a 58.3% gap on every dollar of revenue.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Millrose Properties, Inc. is a U.S.-based real estate enterprise primarily focused on the acquisition, ownership, operation, and management of income-generating multi-family residential assets. Its core markets span the U.S. Mid-Atlantic and Southeast regions, and it also offers professional property management services to select third-party property owners.

GKOS vs MRP — Head-to-Head

Bigger by revenue
MRP
MRP
1.3× larger
MRP
$189.5M
$150.6M
GKOS
Higher net margin
MRP
MRP
58.3% more per $
MRP
64.5%
6.2%
GKOS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GKOS
GKOS
MRP
MRP
Revenue
$150.6M
$189.5M
Net Profit
$9.4M
$122.2M
Gross Margin
77.9%
Operating Margin
9.0%
84.8%
Net Margin
6.2%
64.5%
Revenue YoY
41.2%
Net Profit YoY
285.8%
EPS (diluted)
$0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
MRP
MRP
Q1 26
$150.6M
Q4 25
$143.1M
$189.5M
Q3 25
$133.5M
$179.3M
Q2 25
$124.1M
$149.0M
Q1 25
$106.7M
$82.7M
Q4 24
$105.5M
Q3 24
$96.7M
Q2 24
$95.7M
Net Profit
GKOS
GKOS
MRP
MRP
Q1 26
$9.4M
Q4 25
$-133.7M
$122.2M
Q3 25
$-16.2M
$105.1M
Q2 25
$-19.7M
$112.8M
Q1 25
$-18.1M
$39.8M
Q4 24
$-33.6M
Q3 24
$-21.4M
Q2 24
$-50.5M
Gross Margin
GKOS
GKOS
MRP
MRP
Q1 26
77.9%
Q4 25
-1.1%
Q3 25
78.4%
Q2 25
78.3%
Q1 25
77.2%
Q4 24
72.9%
Q3 24
76.6%
Q2 24
76.4%
Operating Margin
GKOS
GKOS
MRP
MRP
Q1 26
9.0%
Q4 25
-97.7%
84.8%
Q3 25
-12.3%
85.3%
Q2 25
-18.3%
85.1%
Q1 25
-19.4%
55.2%
Q4 24
-27.2%
Q3 24
-25.5%
Q2 24
-31.3%
Net Margin
GKOS
GKOS
MRP
MRP
Q1 26
6.2%
Q4 25
-93.4%
64.5%
Q3 25
-12.2%
58.6%
Q2 25
-15.8%
75.7%
Q1 25
-17.0%
48.1%
Q4 24
-31.8%
Q3 24
-22.1%
Q2 24
-52.8%
EPS (diluted)
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
$-2.34
$0.74
Q3 25
$-0.28
$0.63
Q2 25
$-0.34
$0.68
Q1 25
$-0.32
$0.39
Q4 24
$-0.56
Q3 24
$-0.39
Q2 24
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
MRP
MRP
Cash + ST InvestmentsLiquidity on hand
$276.7M
$35.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
$5.9B
Total Assets
$893.3M
$9.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
MRP
MRP
Q1 26
$276.7M
Q4 25
$90.8M
$35.0M
Q3 25
$98.2M
$242.6M
Q2 25
$100.8M
$66.6M
Q1 25
$114.3M
$89.5M
Q4 24
$169.6M
Q3 24
$100.1M
Q2 24
$68.1M
Stockholders' Equity
GKOS
GKOS
MRP
MRP
Q1 26
$670.9M
Q4 25
$656.2M
$5.9B
Q3 25
$769.5M
$5.9B
Q2 25
$765.1M
$5.9B
Q1 25
$764.0M
$5.9B
Q4 24
$766.9M
Q3 24
$668.5M
Q2 24
$665.2M
Total Assets
GKOS
GKOS
MRP
MRP
Q1 26
$893.3M
Q4 25
$893.5M
$9.3B
Q3 25
$999.4M
$9.0B
Q2 25
$987.0M
$8.0B
Q1 25
$966.2M
$7.2B
Q4 24
$974.8M
Q3 24
$926.5M
Q2 24
$919.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
MRP
MRP
Operating Cash FlowLast quarter
$3.7B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
30.05×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
$6.8M
$3.7B
Q3 25
$-10.1M
$123.1M
Q2 25
$7.0M
$109.1M
Q1 25
$-18.5M
$21.3M
Q4 24
$507.0K
Q3 24
$-9.6M
Q2 24
$-18.4M
Free Cash Flow
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
$3.9M
Q3 25
$-11.7M
Q2 25
$5.8M
Q1 25
$-20.5M
Q4 24
$-1.2M
Q3 24
$-11.0M
Q2 24
$-20.5M
FCF Margin
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
2.7%
Q3 25
-8.8%
Q2 25
4.7%
Q1 25
-19.2%
Q4 24
-1.2%
Q3 24
-11.4%
Q2 24
-21.4%
Capex Intensity
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
0.9%
Q1 25
1.8%
Q4 24
1.6%
Q3 24
1.5%
Q2 24
2.2%
Cash Conversion
GKOS
GKOS
MRP
MRP
Q1 26
Q4 25
30.05×
Q3 25
1.17×
Q2 25
0.97×
Q1 25
0.53×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons